SCHEMBL12447397

SCHEMBL12447397

CC(C)CN1CC[C@@H](c2ccccc2)C1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 6/20 0.56
DRD2 P14416 3/20 0.56
HTR2A P28223 1/20 0.52
HRH1 P35367 1/20 0.52
DRD1 P21728 1/20 0.51
DRD4 P21917 1/20 0.51
DRD5 P21918 1/20 0.51
DRD3 P35462 1/20 0.51
CARM1 Q86X55 1/20 0.51
PRMT6 Q96LA8 1/20 0.51
CCR5 P51681 1/20 0.50
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
MEN1 O00255 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
GRM2 Q14416 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12768109 1.00 SLC18A3 (0.56) SLC18A3DRD2HTR2AHRH1DRD1
SCHEMBL23374659 1.00 SLC18A3 (0.56) SLC18A3DRD2HTR2AHRH1DRD1
SCHEMBL1099798 0.91 SLC18A3 (0.67) SLC18A3DRD2CARM1PRMT6CCR5
SCHEMBL23374534 0.90 DRD2 (0.65) SLC18A3DRD2HTR2ADRD1DRD4
SCHEMBL23374714 0.90 DRD2 (0.65) SLC18A3DRD2HTR2ADRD1DRD4
SCHEMBL18212456 0.85 SLC18A3 (0.46) SLC18A3DRD2HTR2AHRH1DRD1
SCHEMBL14544188 0.85 SLC18A3 (0.45) SLC18A3DRD2HTR2AHRH1DRD4
SCHEMBL8104014 0.81 DRD2 (0.68) SLC18A3DRD2DRD1DRD4DRD5
SCHEMBL23374660 0.80 DRD2 (0.66) SLC18A3DRD2HTR2AHRH1DRD1
SCHEMBL22307922 0.80 DRD2 (0.66) SLC18A3DRD2HTR2AHRH1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548870-B2 Compounds useful as inhibitors of helios protein BRISTOL-MYERS SQUIBB COMPANY (US) 2023-01-10 US disclosed
US-20210147383-A1 COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN BRISTOL-MYERS SQUIBB COMPANY 2021-05-20 US disclosed
EP-2900223-B1 NOVEL COMPOUNDS THAT ARE ERK INHIBITORS MERCK SHARP & DOHME (US) 2017-10-25 EP disclosed
EP-1786815-B1 SPIRO COMPOUNDS AND METHODS FOR THE MODULATION OF CHEMOKINE RECEPTOR ACTIVITY VIROCHEM PHARMA INC (CA) 2011-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147383-A1 COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN IKZF2, RPL6, HNRNPR SLC18A3 4634/4885DRD2 4824/4885HTR2A 4142/4885
US-11548870-B2 Compounds useful as inhibitors of helios protein IKZF2, RPL6, HNRNPR SLC18A3 4634/4885DRD2 4824/4885HTR2A 4142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.